Piramal Pharma Ltd has announced that the Board of Directors of the company will meet on Wednesday, November 5, 2025 to consider and approve the unaudited financial results (Standalone and Consolidated) for the quarter and half year ended September 30, 2025.
The company also informed that the ‘trading window’ for trading in the company’s shares, which is closed from Wednesday, October 1, 2025, will remain closed till Friday, November 7, 2025 (both days inclusive).
This announcement was made on 24 October 2025.
Piramal Pharma Ltd is a pharmaceutical company whose shares are listed on the National Stock Exchange of India Limited (NSE) under the symbol PPLPHARMA and on the Bombay Stock Exchange (BSE) under the script code 543635.
The registered office of the company is Gr. Flr. Piramal Ananta is located at Agastya Corporate Park, Opp Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, India.
The corporate identity number (CIN) of the company is L24297MH2020PLC338592.
The announcement was signed by company secretary Tanya Sanish.
The company’s email address for correspondence is shareholders.ppl@piramal.com and website is piramalpharma.com.